Raras
Buscar doenças, sintomas, genes...
Síndrome cerebro-fronto-facial Baraitser-Winter
ORPHA:2995CID-10 · Q87.0DOENÇA RARA

A Síndrome de Baraitser-Winter (BWS) é uma condição que causa má-formações, caracterizada por: características faciais particulares (como olhos mais espaçados com pálpebras caídas, nariz largo e arredondado, uma linha óssea saliente na testa – sutura metópica –, sobrancelhas arqueadas e um engrossamento progressivo das feições do rosto ao longo do tempo); um defeito nos olhos chamado coloboma ocular (uma falha no desenvolvimento de alguma parte do olho); alterações no cérebro, como dobras cerebrais mais grossas e em menor número (paquigiria) e/ou áreas onde as células cerebrais estão fora do lugar, formando faixas anormais (heterotopias em faixa), com um padrão que geralmente vai da frente para trás no cérebro; enrijecimento progressivo das articulações; e deficiência intelectual de gravidade variável, frequentemente acompanhada de epilepsia grave. A combinação de paquigiria (dobras cerebrais anormais), epilepsia, deficiência intelectual e as características faciais particulares (dismorfismo), também conhecida como Síndrome de Fryns-Aftimos (FA), corresponde à forma como a BWS se manifesta em pacientes mais velhos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A Síndrome de Baraitser-Winter (BWS) é uma condição que causa má-formações, caracterizada por: características faciais particulares (como olhos mais espaçados com pálpebras caídas, nariz largo e arredondado, uma linha óssea saliente na testa – sutura metópica –, sobrancelhas arqueadas e um engrossamento progressivo das feições do rosto ao longo do tempo); um defeito nos olhos chamado coloboma ocular (uma falha no desenvolvimento de alguma parte do olho); alterações no cérebro, como dobras cerebrais mais grossas e em menor número (paquigiria) e/ou áreas onde as células cerebrais estão fora do lugar, formando faixas anormais (heterotopias em faixa), com um padrão que geralmente vai da frente para trás no cérebro; enrijecimento progressivo das articulações; e deficiência intelectual de gravidade variável, frequentemente acompanhada de epilepsia grave. A combinação de paquigiria (dobras cerebrais anormais), epilepsia, deficiência intelectual e as características faciais particulares (dismorfismo), também conhecida como Síndrome de Fryns-Aftimos (FA), corresponde à forma como a BWS se manifesta em pacientes mais velhos.

Publicações científicas
35 artigos
Último publicado: 2026 Jan

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
60
pacientes catalogados
Início
Antenatal
+ infancy, neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q87.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

😀
Face
17 sintomas
🧠
Neurológico
11 sintomas
🦴
Ossos e articulações
7 sintomas
👁️
Olhos
6 sintomas
📏
Crescimento
6 sintomas
👂
Ouvidos
4 sintomas

+ 31 sintomas em outras categorias

Características mais comuns

90%prev.
Euriblefaron
Muito frequente (99-80%)
90%prev.
Filtro longo
Muito frequente (99-80%)
90%prev.
Paquigiria
Muito frequente (99-80%)
90%prev.
Lissencefalia
Muito frequente (99-80%)
90%prev.
Polimicrogiria
Muito frequente (99-80%)
90%prev.
Crista metópica proeminente
Muito frequente (99-80%)
89sintomas
Muito frequente (37)
Frequente (17)
Ocasional (7)
Sem dados (28)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 89 características clínicas mais associadas, ordenadas por frequência.

EuriblefaronEuryblepharon
Muito frequente (99-80%)90%
Filtro longoLong philtrum
Muito frequente (99-80%)90%
PaquigiriaPachygyria
Muito frequente (99-80%)90%
LissencefaliaLissencephaly
Muito frequente (99-80%)90%
PolimicrogiriaPolymicrogyria
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico35PubMed
Últimos 10 anos32publicações
Pico20256 papers
Linha do tempo
2026Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Not applicable.

ACTBActin, cytoplasmic 1Disease-causing germline mutation(s) (gain of function) inAltamente restrito
FUNÇÃO

Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (PubMed:25255767, PubMed:29581253). Actin exists in both monomeric (G-actin) and polymeric (F-actin) forms, both forms playing key functions, such as cell motility and contraction (PubMed:29581253). In addition to their role in the cytoplasmic cytoskeleton, G- and F-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damage

LOCALIZAÇÃO

Cytoplasm, cytoskeletonNucleus

VIAS BIOLÓGICAS (10)
Paradoxical activation of RAF signaling by kinase inactive BRAFSignaling by moderate kinase activity BRAF mutantsSignaling by high-kinase activity BRAF mutantsSignaling downstream of RAS mutantsMAP2K and MAPK activation
MECANISMO DE DOENÇA

Dystonia-deafness syndrome 1

An autosomal dominant form of dystonia with juvenile onset, associated with congenital or childhood-onset sensorineural deafness. Dystonia is defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. Some DDS1 patients have dysmorphic features, skeletal anomalies, and/or mild developmental delay with impaired intellectual development.

OUTRAS DOENÇAS (7)
developmental malformations-deafness-dystonia syndromecongenital smooth muscle hamartoma, with or without hemihypertrophyBaraitser-Winter syndrome 1Becker nevus syndrome
HGNC:132UniProt:P60709
ACTG1Actin, cytoplasmic 2Disease-causing germline mutation(s) (gain of function) inModerado
FUNÇÃO

Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. May play a role in the repair of noise-induced stereocilia gaps thereby maintains hearing sensitivity following loud noise damage (By similarity)

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

VIAS BIOLÓGICAS (10)
Paradoxical activation of RAF signaling by kinase inactive BRAFSignaling by moderate kinase activity BRAF mutantsSignaling by high-kinase activity BRAF mutantsSignaling downstream of RAS mutantsMAP2K and MAPK activation
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 20

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (6)
autosomal dominant nonsyndromic hearing loss 20Baraitser-winter syndrome 2Baraitser-Winter cerebrofrontofacial syndromecoloboma of iris
HGNC:144UniProt:P63261

Variantes genéticas (ClinVar)

422 variantes patogênicas registradas no ClinVar.

🧬 ACTB: NM_001101.5(ACTB):c.254T>C (p.Ile85Thr) ()
🧬 ACTB: NM_001101.5(ACTB):c.793T>A (p.Ser265Thr) ()
🧬 ACTB: NM_001101.5(ACTB):c.915G>A (p.Met305Ile) ()
🧬 ACTB: NM_001101.5(ACTB):c.901G>A (p.Gly301Ser) ()
🧬 ACTB: GRCh37/hg19 7p22.2-21.3(chr7:3876162-11345148)x3 ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome cerebro-fronto-facial Baraitser-Winter

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
34 papers (10 anos)
#1

Molecular genotype-phenotype correlation in ACTB- and ACTG1-related non-muscle actinopathies.

American journal of human genetics2026 Feb 05

Recent advances in Mendelian genomics reveal the importance of variant-level characterization of allelic disorders. Non-muscle actin isoforms, encoded by the genes ACTB and ACTG1, are the most abundant intracellular proteins, but historically, they are often regarded as merely being "housekeeping" molecules. Here, we illuminate the extraordinary clinical heterogeneity and complex pathobiology of genetic non-muscle actinopathies. To do this, we combine human genomics studies with molecular biology. Strikingly, variants in ACTB and ACTG1 isoforms generate at least eight distinct clinical disorders. A subset of disease-associated missense variants causes dysregulated actin polymerization-depolymerization and neuronal migration defects. In contrast, nonsense, frameshift, and missense variants enhancing protein degradation cause milder phenotypes or are benign. These results emphasize the essential functional aspects of the non-muscle actin isoforms. Critically, they additionally constitute a template for the personalized genetic variant-level-driven management of the pleiotropic allelic single-gene disorders.

#2

The Baraitser-Winter Cerebrofrontofacial Syndrome Recurrent R196H Variant in Cytoplasmic β-Actin Impairs Its Cellular Polymerization and Stability.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology2026 Jan 15

Variants in cytoskeletal actin encoding genes are associated with a broad spectrum of disorders, called non-muscle actinopathies. Among them, the Baraitser-Winter cerebrofrontofacial syndrome (BWCFF) displays the most severe symptoms, such as intellectual disability and epilepsy. We found that the BWCFF-associated R196H mutation results in reduced proliferation and migration of patient-derived fibroblast cells, and the latter is likely related to decreased fibronectin expression. The mutation causes a 50% drop in filamentous (F-) actin content, which is correlated with an approximately fourfold reduction in the stiffness of patient-derived cells probed with atomic force microscopy (AFM). We observed no significant defects either in the organization of the cellular actin cytoskeleton, analyzed by superresolution (STED) microscopy, or in the structure of purified filaments, explored with AFM. On the other hand, the more parallel orientation of the mutant actin bundles might be caused by the perturbed interaction of actin with the Arp2/3 complex. Manipulating the cells by mechanical forces through the application of the dual laser optical tweezers (DLOT) technique suggests that the mutation weakens the attachment of cytoskeletal actin to the plasma membrane. Inducing dynamic reorganization of actin by uniaxial stretching revealed that the interaction of cofilin with actin is also weakened by the mutation. Thus, the impaired function of actin to form filaments and interact with either cofilin or the Arp2/3 complex may result in the malfunction of dendritic spines, and the reduced cellular proliferation and migration might account for the lissencephaly phenotype of patients.

#3

Cerebral organoids expressing mutant actin genes reveal cellular mechanism underlying microcephaly.

EMBO reports2026 Jan

Actins are cytoskeletal proteins that are essential for multiple cellular processes. Mutations in the ACTB and ACTG1 genes, encoding the ubiquitous beta- and gamma-cytoskeletal actin isoforms, respectively, cause a broad spectrum of neurodevelopmental disorders, with microcephaly as the most frequent one. To investigate the pathogenesis underlying this cortical malformation, we studied patient-derived cerebral organoids from induced pluripotent stem cells of individuals with the Baraitser-Winter-CerebroFrontoFacial syndrome (BWCFF-S) carrying an ACTB/ACTG1 missense mutation. These organoids were reduced in size, showing a thinner ventricular zone (VZ) due to reduced VZ progenitor abundance. Strikingly, VZ progenitors in BWCFF-S cerebral organoids displayed a shift in the orientation of their cleavage plane from a predominantly vertical to a majoritarian horizontal orientation. The latter cleavage plane orientation is incompatible with increasing VZ progenitor abundance and instead promotes basal progenitor generation. Various cytoskeletal and morphological irregularities of BWCFF-S VZ progenitors, notably in the apical region, seemingly contribute to this change in cleavage plane orientation. Our results provide insight into the cell biological basis of the microcephaly associated with BWCFF-S caused by actin mutations.

#4

Mechanics of blunting of actin-myosin interaction dynamics by the actinopathy-causing mutation E334Q in cytoskeletal γ-actin.

The Journal of physiology2026 Jan

Cellular processes such as cytokinesis, apoptosis and migration rely heavily on the myosin-based contractility of the γ-actin network in the submembrane cortex. Direct measurements of γ-actin-myosin interactions through morphological and depletion investigations remain elusive. Here, we use a synthetic nanomachine, consisting of an array of myosin motors carried on a nanopositioner and brought to interact with an actin filament attached to a bead trapped in the focus of dual laser optical tweezers. The nanomachine is able to mimic the loading conditions of γ-actin-myosin interactions in situ, allowing measurements of the maximum steady force (F0) and of the shortening velocity against loads < F0. Comparative measurements are conducted on wild-type γ-actin and γ-actin carrying the E334Q mutation, associated with non-muscle actinopathies. Our results show that the force of the single actin-myosin interaction is 2.5 pN for the wild-type actin and is halved by the mutation. The kinetics of motor attachment-detachment, underpinning the rate of isometric force rise and the force-velocity relation, are also reduced by a factor of two, resulting in a reduction of the maximum nanomachine power to one-fifth. The identification and quantitative definition of the loss of basic function caused by the E334Q γ-actin mutation serve as a starting point for understanding the chain of remodelling events leading to the pathological phenotype and demonstrate the potential of the nanomachine for targeted therapeutic interventions. KEY POINTS: Mutations in cytoskeletal actin cause rare pathologies classified as non-muscle actinopathies (NMAs), including the Baraitser-Winter cerebrofrontofacial syndrome characterized by neural cortex abnormalities leading to facial dysmorphism, developmental delay and organ malformations. Cytoskeleton dynamics control cell morphology and migration and rely on the interaction of non-muscle myosin II with cytoskeletal γ-actin, but the system's mechanical performance and its blunting by NMA-causing mutations in γ-actin have still to be defined. Here, a synthetic nanomachine is used to record the relevant mechano-kinetic parameters of the γ-actin-myosin interaction under physiological loading conditions. Quantitative estimates of these parameters for wild-type and E334Q mutant γ-actin suggest that strong defects in the actin-myosin interaction mechanics may be one of the main molecular mechanisms leading to the pathological phenotype. This paper lays the groundwork for the quantitative definition of the basic function altered by NMA-causing mutations and the evaluation of targeted therapies.

#5

Novel MYH10 heterozygous variants associated to a syndrome combining mainly ptosis and ocular coloboma expand the MYH10 related phenotypes.

European journal of human genetics : EJHG2025 Nov

Syndromes associating both eyeball and periocular developmental anomalies, combining iris chorioretinal (ocular) coloboma and ptosis, are described in very rare clinical entities such as Baraitser-Winter cerebrofrontofacial syndrome (BWCFF). We report on six individuals from 3 unrelated families presenting with autosomal dominant eye malformations, including ocular coloboma, ptosis and craniofacial features suggesting BWCFF. However, no neurodevelopmental disorders (NDD) as usually observed in this syndrome were detected. Exome sequencing (ES) or genome sequencing (GS) was performed and allowed the identification of 3 novel heterozygous variants in the MYH10 gene, encoding the non-muscle myosin heavy chain II B. These 3 likely causative variants occur in the MYH10 tail domain required for myosin filament assembly. The MYH10 protein is mislocalized leading to abnormal actin networks in the patients' fibroblasts compared to controls. MYH10 dysfunction leads to delayed development of the eye, as well as a muscular phenotype in the zebrafish model. Heterozygous variants in MYH10 have been recently reported to be associated with an autosomal dominant NDD with other congenital anomalies, but no patients were reported with the association of ocular coloboma and ptosis as main features. Herein, we report other MYH10 variants which cause mainly an ophthalmic phenotype without NDD expanding the phenotype associated with MYH10 and representing a differential diagnosis with BWCFF. The reason for the genotype-phenotype variability with either prominent NDD or prominent ocular features will require further investigations.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC19 artigos no totalmostrando 32

2026

Molecular genotype-phenotype correlation in ACTB- and ACTG1-related non-muscle actinopathies.

American journal of human genetics
2026

The Baraitser-Winter Cerebrofrontofacial Syndrome Recurrent R196H Variant in Cytoplasmic β-Actin Impairs Its Cellular Polymerization and Stability.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2026

Cerebral organoids expressing mutant actin genes reveal cellular mechanism underlying microcephaly.

EMBO reports
2025

Gastrointestinal malrotation and chronic intestinal pseudo-obstruction in two pediatric patients with Baraitser-Winter cerebrofrontofacial syndrome.

JPGN reports
2026

Mechanics of blunting of actin-myosin interaction dynamics by the actinopathy-causing mutation E334Q in cytoskeletal γ-actin.

The Journal of physiology
2025

ACTB deletions or single-nucleotide loss-of-function variants: expansion and further delineation of the phenotype and review of the literature.

Journal of medical genetics
2025

A case of Baraitser-Winter cerebrofrontofacial syndrome diagnosed by whole-exome sequencing.

Human genome variation
2025

Disruption of SETD3-mediated histidine-73 methylation by the BWCFF-associated β-actin G74S mutation.

FEBS letters
2025

Novel MYH10 heterozygous variants associated to a syndrome combining mainly ptosis and ocular coloboma expand the MYH10 related phenotypes.

European journal of human genetics : EJHG
2025

Molecular mechanisms of hotspot variants in cytoskeletal β-actin associated with Baraitser-Winter syndrome.

The FEBS journal
2024

Derivation of induced pluripotent stem cell from a Baraitser-Winter Cerebrofrontofacial syndrome with ACTB mutation.

Stem cell research
2024

Compromised actin dynamics underlie the orofacial cleft in Baraitser-Winter Cerebrofrontofacial syndrome with a variant in ACTB.

Human molecular genetics
2024

Expansion of the prenatal phenotype of Baraitser-Winter syndrome: Presentation of two cases of multiple congenital anomaly syndrome.

American journal of medical genetics. Part A
2024

The non-muscle actinopathy-associated mutation E334Q in cytoskeletal γ-actin perturbs interaction of actin filaments with myosin and ADF/cofilin family proteins.

eLife
2022

Obsessive-compulsive symptoms in ACTG1-associated Baraitser-Winter cerebrofrontofacial syndrome.

Journal of neural transmission (Vienna, Austria : 1996)
2022

Identification of a De Novo Heterozygous Missense ACTB Variant in Baraitser-Winter Cerebrofrontofacial Syndrome.

Frontiers in genetics
2022

Frameshift mutation S368fs in the gene encoding cytoskeletal β-actin leads to ACTB-associated syndromic thrombocytopenia by impairing actin dynamics.

European journal of cell biology
2022

A de novo ACTB gene pathogenic variant in identical twins with phenotypic variation for hydrops and jejunal atresia.

American journal of medical genetics. Part A
2021

Prenatal diagnosis of Baraitser - Winter syndrome using exome sequencing: Clinical report and review of literature.

European journal of medical genetics
2020

Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing.

American journal of medical genetics. Part A
2020

Baraitser-Winter cerebrofrontofacial syndrome: Report of two adult siblings.

American journal of medical genetics. Part A
2020

Previously undescribed phenotypic findings and novel ACTG1 gene pathogenic variants in Baraitser-Winter cerebrofrontofacial syndrome.

European journal of medical genetics
2020

Further delineation of putative ACTB loss-of-function variants: A 4-patient series.

Human mutation
2019

Prenatal presentation in a patient with Baraitser-Winter cerebrofrontofacial syndrome and a novel ACTB variant.

Clinical dysmorphology
2018

Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia.

Nature communications
2018

Child with cerebral malformations and epilepsy.

The International journal of neuroscience
2017

Pathogenic Variant in ACTB, p.Arg183Trp, Causes Juvenile-Onset Dystonia, Hearing Loss, and Developmental Delay without Midline Malformation.

Case reports in genetics
2017

Generalized epilepsy in Baraitser-Winter cerebrofrontofacial syndrome.

Epilepsy &amp; behavior case reports
2017

Acute myeloid leukemia in Baraitser-Winter cerebrofrontofacial syndrome.

American journal of medical genetics. Part A
2017

Baraitser-Winter cerebrofrontofacial syndrome.

Clinical genetics
2016

Update on the ACTG1-associated Baraitser-Winter cerebrofrontofacial syndrome.

American journal of medical genetics. Part A
2015

Rare ACTG1 variants in fetal microlissencephaly.

European journal of medical genetics

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome cerebro-fronto-facial Baraitser-Winter.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome cerebro-fronto-facial Baraitser-Winter

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Molecular genotype-phenotype correlation in ACTB- and ACTG1-related non-muscle actinopathies.
    American journal of human genetics· 2026· PMID 41529692mais citado
  2. The Baraitser-Winter Cerebrofrontofacial Syndrome Recurrent R196H Variant in Cytoplasmic &#x3b2;-Actin Impairs Its Cellular Polymerization and Stability.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology· 2026· PMID 41489609mais citado
  3. Cerebral organoids expressing mutant actin genes reveal cellular mechanism underlying microcephaly.
    EMBO reports· 2026· PMID 41372632mais citado
  4. Mechanics of blunting of actin-myosin interaction dynamics by the actinopathy-causing mutation E334Q in cytoskeletal &#x3b3;-actin.
    The Journal of physiology· 2026· PMID 41243338mais citado
  5. Novel MYH10 heterozygous variants associated to a syndrome combining mainly ptosis and ocular coloboma expand the MYH10 related phenotypes.
    European journal of human genetics : EJHG· 2025· PMID 40044823mais citado
  6. A Novel ACTB Truncating Variant in a Neonate with ACTB-Related Neurodevelopmental Disorder with Features Overlapping Baraitser-Winter Cerebrofrontofacial Syndrome Diagnosed Using Whole Genome Sequencing: A Case Report.
    Ann Clin Lab Sci· 2026· PMID 41927119recente
  7. Gastrointestinal malrotation and chronic intestinal pseudo-obstruction in two pediatric patients with Baraitser-Winter cerebrofrontofacial syndrome.
    JPGN Rep· 2025· PMID 41245037recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2995(Orphanet)
  2. MONDO:0017579(MONDO)
  3. GARD:5279(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q18966102(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome cerebro-fronto-facial Baraitser-Winter
Compêndio · Raras BR

Síndrome cerebro-fronto-facial Baraitser-Winter

ORPHA:2995 · MONDO:0017579
Prevalência
<1 / 1 000 000
Casos
60 casos conhecidos
Herança
Autosomal dominant, Not applicable
CID-10
Q87.0 · Síndromes com malformações congênitas afetando predominantemente o aspecto da face
Início
Antenatal, Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1853623
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades